PlexBKV


PlexBKV

  • The PlexBKV blood test measures cell-based immunity to the BK virus, a type of polyoma virus.
  • The BK virus can cause infection in any age group. Symptoms can be mild. After infection, the virus can persist in the body. The virus can reactivate in individuals with immune systems which have been weakened by disease and immunosuppressive drugs.
  • In kidney transplant recipients the BK virus can infect the transplanted kidney. This condition is called BK nephropathy. If unchecked, BK nephropathy can cause the kidney to fail.
  • Reducing immunosuppression can help lower BK virus levels in urine and blood. In some patients, these levels are unaffected and the organ can experience rejection.
  • BK virus infection is accompanied by the loss of cell-based immunity to EBV.
  • Knowledge about immunity to the BK virus can help physicians determine when to start, stop, or continue therapy.
  • This test is under development. If you are interested in learning more, please subscribe to our updates.

  • To order tests or clarify questions, please reach us via email info@plexision.com or call us at +1 (855) 753-9474.

The PlexBKV blood test measures cell-based immunity to the BK virus, a type of polyoma virus.

logo

Developing cellular biomarkers for personalized diagnosis and drug development in infectious diseases, solid organ transplantation, as well as immunological disorders.

CONTACT US

  • Contact us
    4424 Penn Ave., #202,
    Pittsburgh, PA 15224 USA
  • Mail Us
    info@plexision.com
  • Phone
    +1 (855) 753-9474
© Copyright Plexision 2020. All Rights Reserved.

About

Plexision develops cellular biomarkers for personalized diagnosis and drug development in solid organ transplantation and immunological disorders. We also pioneer in R&D projects centered on integrating biomarker targets in all phases of drug development, from preclinical to post-marketing. Plexision’s technology can be adapted to

  • - Assess disease risk for several immunological disorders.
  • - Predict the success of a drug for a specific patient.
  • - Develop dosing recommendations for new immunological drugs.

Our state-of-the-art laboratory is CLIA-certified and located in Pittsburgh, PA.

Contact